IP Library Assignment 044696/0702
Patent Assignment
Reel/Frame 044696/0702

Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 043793 Frame 0436. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2017-12-05 Pages: 8
Assignor
ARCHIMEDES DEVELOPMENT LIMITED
Executed: 2017-07-31
Assignees
ARCHIMEDES DEVELOPMENT LIMITED
ALBERT EINSTEIN CENTER, NOTTINGHAM SCIENCE & TECHNOLOGY PARK, UNIVERSITY BOULEVARD, NOTTINGHAM, NG7 2TN, UNITED KINGDOM
PHARMALINK AB
WALLINGATAN 26B, STOCKHOLM, SE-111 24, SWEDEN
Covered Property (1)
Compositions for the Oral Delivery of Corticosteroids
Patent: 8,491,932 →
Application: 12/992,182 →
Publication: US 2011/0104269
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 20, 2011
From: WATTS, PETER; DYER, ANN MARGARET
To: ARCHIMEDES DEVELOPMENT LIMITED
Reel/Frame 025666/0615 →
Assignment of Assignor's Interest Oct 5, 2017
From: ARCHIMEDES DEVELOPMENT LIMITED
To: PHARMALINK AB
Reel/Frame 043793/0436 →
Change of Name Nov 28, 2018
From: PHARMALINK AB
To: CALLIDITAS THERAPEUTICS AB
Reel/Frame 047653/0136 →
Change of Name Jun 8, 2020
From: ARCHIMEDES DEVELOPMENT LIMITED
To: KYOWA KIRIN SERVICES LTD.
Reel/Frame 052865/0771 →
Security Interest Jul 21, 2021
From: CALLIDITAS THERAPEUTICS AB
To: KREOS CAPITAL VI (UK) LIMITED; KREOS CAPITAL 2020 OPPORTUNITY (UK) LIMITED
Reel/Frame 056938/0233 →
Release of Security Interest Dec 28, 2023
From: KREOS CAPITAL VI (UK) LIMITED; KREOS CAPITAL 2020 OPPORTUNITY (UK) LIMITED
To: CALLIDITAS THERAPEUTICS AB
Reel/Frame 065975/0695 →
Security Interest Dec 29, 2023
From: CALLIDITAS THERAPEUTICS AB
To: ATHYRIUM OPPORTUNITIES IV CO-INVEST 1 LP, AS ADMINISTRATIVE AGENT
Reel/Frame 065984/0539 →
Release of Security Interest Sep 13, 2024
From: ATHYRIUM OPPORTUNITIES IV CO-INVEST 1 LP
To: CALLIDITAS THERAPEUTICS AB
Reel/Frame 068578/0153 →